Paper41595249
Two-Stage Microwave Hyperthermia Using Magnetic Nanoparticles for Optimal Chemotherapy Activation in Liver Cancer: Concept and Preliminary Tests on Wistar Rat Model.
Schreiner OD and 3 others. Cancers (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Two-Stage Microwave Hyperthermia Using Magnetic Nanoparticles for Optimal Chemotherapy Activation in Liver Cancer: Concept and Preliminary Tests on Wistar Rat Model. Papers, record 41595249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41595249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Two-Stage Microwave Hyperthermia Using Magnetic Nanoparticles for Optimal Chemotherapy Activation in Liver Cancer: Concept and Preliminary Tests on Wistar Rat Model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34884853 | Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884853 | PubMed |
| 2 | 24053166 | A three-dimensional visualisation preoperative treatment planning system in microwave ablation for liver cancer: a preliminary clinical application. | Int J Hyperthermia | 2013 | https://conductscience.org/library/papers/24053166 | PubMed |
| 3 | 33808973 | Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33808973 | PubMed |
| 4 | 23028225 | Biocompatibility of magnetic Fe₃O₄ nanoparticles and their cytotoxic effect on MCF-7 cells. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/23028225 | PubMed |
| 5 | 8938026 | The dielectric properties of biological tissues: III. Parametric models for the dielectric spectrum of tissues. | Phys Med Biol | 1996 | https://conductscience.org/library/papers/8938026 | PubMed |
| 6 | 11280396 | 2000 Report of the AVMA Panel on Euthanasia. | J Am Vet Med Assoc | 2001 | https://conductscience.org/library/papers/11280396 | PubMed |
| 7 | 26032500 | Non-lethal heat treatment of cells results in reduction of tumor initiation and metastatic potential. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/26032500 | PubMed |
| 8 | 38163404 | A two-stage exacerbated hypoxia nanoengineering strategy induced amplifying activation of tirapazamine for microwave hyperthermia-chemotherapy of breast cancer. | J Colloid Interface Sci | 2024 | https://conductscience.org/library/papers/38163404 | PubMed |
| 9 | 40688660 | Magnetic hyperthermia in oncology: Nanomaterials-driven combinatorial strategies for synergistic therapeutic gains. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40688660 | PubMed |
| 10 | 32695968 | New frontiers in liver resection for hepatocellular carcinoma. | JHEP Rep | 2020 | https://conductscience.org/library/papers/32695968 | PubMed |
| 11 | 32421646 | Optimization of power used in liver cancer microwave therapy by injection of Magnetic Nanoparticles (MNPs). | Comput Biol Med | 2020 | https://conductscience.org/library/papers/32421646 | PubMed |
| 12 | 35316317 | Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: recent advancements, molecular effects, and future directions in the omics era. | Biomater Sci | 2022 | https://conductscience.org/library/papers/35316317 | PubMed |
| 13 | 35426612 | Modeling of interstitial microwave hyperthermia for hepatic tumors using floating sleeve antenna. | Phys Eng Sci Med | 2022 | https://conductscience.org/library/papers/35426612 | PubMed |
| 14 | 39227359 | Global epidemiology of liver cancer 2022: An emphasis on geographic disparities. | Chin Med J (Engl) | 2024 | https://conductscience.org/library/papers/39227359 | PubMed |
| 15 | 36978852 | Redox Signaling in Plant Heat Stress Response. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36978852 | PubMed |
| 16 | 35453310 | Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35453310 | PubMed |
| 17 | 22261395 | A noninvasive, remote and precise method for temperature and concentration estimation using magnetic nanoparticles. | Nanotechnology | 2012 | https://conductscience.org/library/papers/22261395 | PubMed |
| 18 | 35530735 | Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review. | Front Public Health | 2022 | https://conductscience.org/library/papers/35530735 | PubMed |
| 19 | 39065020 | Optimisation of a Microwave Synthesis of Silver Nanoparticles by a Quality by Design Approach to Improve SERS Analytical Performances. | Molecules | 2024 | https://conductscience.org/library/papers/39065020 | PubMed |
| 20 | 34835777 | Iron Oxide Nanoparticle-Based Hyperthermia as a Treatment Option in Various Gastrointestinal Malignancies. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/34835777 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41595249
GET https://conductscience.org/api/papers/v1/41595249/references?page=2